+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radiotheranostics Market Size, Share & Trends Analysis Report by Radioisotope, Approach, Application, Region, and Segment Forecasts, 2026-2033- Product Image
Radiotheranostics Market Size, Share & Trends Analysis Report by Radioisotope, Approach, Application, Region, and Segment Forecasts, 2026-2033- Product Image
New

Radiotheranostics Market Size, Share & Trends Analysis Report by Radioisotope, Approach, Application, Region, and Segment Forecasts, 2026-2033

  • PDF Icon

    Report

  • 150 Pages
  • January 2026
  • Region: Global
  • Grand View Research
  • ID: 5830901
REQUEST CUSTOMIZATION
Description Jump to:
The global radiotheranostics market size was estimated at USD 11.79 billion in 2025 and is projected to reach USD 25.56 billion by 2033, growing at a CAGR of 9.5% from 2026 to 2033. The market represents a precision medicine approach that integrates molecular imaging with targeted radionuclide therapy to enhance patient selection, treatment accuracy, and longitudinal outcome monitoring.

By unifying diagnostics and therapy around the same biological target, radiotheranostics reduces clinical uncertainty, supports individualized dosing strategies, and enables more efficient utilization of advanced oncology resources. For instance, in March 2025, according to Actinium Pharmaceuticals, the company announced progress in its radiotheranostic pipeline, underscoring continued development of targeted radiopharmaceutical therapies, reflecting broader industry momentum toward clinically validated, target-driven treatment platforms. Market adoption is supported by expanding clinical evidence, increasing regulatory acceptance of targeted radiopharmaceuticals, and growing uptake across specialized oncology and nuclear medicine centers, while progression is moderated by constraints related to isotope availability, manufacturing scalability, infrastructure readiness, and reimbursement alignment. Strategic priorities across the ecosystem include innovation in targeting ligands, long-term isotope supply partnerships, and service delivery models that ensure consistent and compliant clinical deployment across care settings.

The current radiotheranostics market scenario is characterized by steady clinical expansion and increasing operational sophistication, as the modality moves from early adoption toward more structured integration within oncology care pathways. Development activity is increasingly focused on improving targeting accuracy, optimizing radionuclide selection, and embedding advanced imaging and dosimetry tools to support personalized treatment planning. Innovation is no longer limited to established peptide based radioligands, with growing investment in antibody fragments, engineered peptides, and small molecule vectors that enhance tumor specificity and therapeutic index. Parallel advances in alpha emitter programs are shaping next generation pipelines aimed at addressing resistant and metastatic disease settings.

Despite this momentum, market progression continues to be moderated by practical constraints related to isotope availability, manufacturing scalability, cold chain logistics, and infrastructure readiness across treatment centers. Health systems are evaluating hub and spoke delivery models and external radiopharmacy partnerships to manage complexity while preserving access. Reimbursement alignment remains a critical factor, as payers assess clinical value across both diagnostic and therapeutic components. For instance, in October 2024, according to SHINE Technologies (company press release), collaborative preclinical research demonstrated promising tumor regression outcomes for novel radiotheranostic candidates in prostate and kidney cancer models, underscoring sustained innovation at the intersection of isotope production and targeted radiopharmaceutical development.

Global Radiotheranostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global radiotheranostics market report based on radioisotope, approach, application, and region:

Radioisotope Outlook (Revenue, USD Million, 2021-2033)

  • Iodine-131
  • Iodine-123
  • Gallium-68
  • Lutetium-177
  • 18F with Y-90
  • Others

Approach Outlook (Revenue, USD Million, 2021-2033)

  • Targeted Therapeutic
  • Targeted Diagnostic

Application Outlook (Revenue, USD Million, 2021-2033)

  • Oncology
  • Non-Oncology

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation & Scope
1.2 Segment Definitions
1.2.1 Radioisotope
1.2.2 Approach
1.2.3 Application
1.3 Estimates and Forecast Timeline
1.4 Research Methodology
1.5 Information Procurement
1.5.1 Purchased Database
1.5.2 Internal Database
1.5.3 Secondary Sources
1.5.4 Primary Research
1.6 Information Analysis
1.6.1 Data Analysis Models
1.7 Market Formulation & Data Visualization
1.8 Model Details
1.8.1 Commodity Flow Analysis
1.9 List of Secondary Sources
1.10 Objectives
Chapter 2. Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Radiotheranostics Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 Business Environment Analysis
3.3.1 Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1 Supplier Power
3.3.1.2 Buyer Power
3.3.1.3 Substitution Threat
3.3.1.4 Threat of New Entrants
3.3.1.5 Competitive Rivalry
3.3.2 PESTLE Analysis
3.3.3 Pipeline Analysis
3.3.4 Patent Expiry Analysis
3.3.5 Pricing Analysis
Chapter 4. Radiotheranostics Market: Radioisotope Business Analysis
4.1. Radioisotope Market Share, 2025 & 2033
4.2. Radioisotope Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Radioisotope, 2021 to 2033 (USD Million)
4.4. Iodine-131
4.4.1 Iodine-131 Market, 2021-2033 (USD Million)
4.5. Iodine-123
4.5.1 Iodine-123 Market, 2021-2033 (USD Million)
4.6. Gallium-68
4.6.1 Gallium-68 Market, 2021-2033 (USD Million)
4.7. Lutetium-177
4.7.1 Lutetium-177 Market, 2021-2033 (USD Million)
4.8. 18F with Y-90
4.8.1 18F with Y-90 Market, 2021-2033 (USD Million)
4.9. Others
4.9.1 Others Market, 2021-2033 (USD Million)
Chapter 5. Radiotheranostics Market: Approach Business Analysis
5.1. Approach Market Share, 2025 & 2033
5.2. Approach Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Approach, 2021 to 2033 (USD Million)
5.4. Targeted Therapeutic
5.4.1 Targeted Therapeutic Market, 2021-2033 (USD Million)
5.5. Targeted Diagnostic
5.5.1 Targeted Diagnostic Market, 2021-2033 (USD Million)
Chapter 6. Radiotheranostics Market: Application Business Analysis
6.1. Application Market Share, 2025 & 2033
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Oncology
6.4.1 Oncology Market, 2021-2033 (USD Million)
6.4.1.1 Thyroid Cancer Market, 2021-2033 (USD Million)
6.4.1.2 Neuroendocrine Tumor Market, 2021-2033 (USD Million)
6.4.1.3 Hepatocellular Carcinoma Market, 2021-2033 (USD Million)
6.4.1.4 Prostate Cancer Market, 2021-2033 (USD Million)
6.4.1.5 Others Market, 2021-2033 (USD Million)
6.5. Non-Oncology
6.5.1 Non-Oncology Market, 2021-2033 (USD Million)
6.5.1.1 Neurological Disorders Market, 2021-2033 (USD Million)
6.5.1.2 Arthritis Market, 2021-2033 (USD Million)
6.5.1.3 Others Market, 2021-2033 (USD Million)
Chapter 7. Radiotheranostics Market: Regional Estimates & Trend Analysis
7.1 Regional Market Share Analysis, 2025 & 2033
7.2 Regional Market Dashboard
7.3 Market Size & Forecasts Trend Analysis, 2021 to 2033:
7.4 North America
7.4.1 North America Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
7.4.2 U.S.
7.4.2.1 Key Country Dynamics
7.4.2.2 Regulatory Framework
7.4.2.3 Reimbursement Scenario
7.4.2.4 U.S. Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.3 Canada
7.4.3.1 Key Country Dynamics
7.4.3.2 Regulatory Framework
7.4.3.3 Reimbursement Scenario
7.4.3.4 Canada Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.4 Mexico
7.4.4.1 Key Country Dynamics
7.4.4.2 Regulatory Framework
7.4.4.3 Reimbursement Scenario
7.4.4.4 Mexico Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5 Europe
7.5.1 Europe Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
7.5.2 UK
7.5.2.1 Key Country Dynamics
7.5.2.2 Regulatory Framework
7.5.2.3 Reimbursement Scenario
7.5.2.4 UK Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.3 Germany
7.5.3.1 Key Country Dynamics
7.5.3.2 Regulatory Framework
7.5.3.3 Reimbursement Scenario
7.5.3.4 Germany Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.4 France
7.5.4.1 Key Country Dynamics
7.5.4.2 Regulatory Framework
7.5.4.3 Reimbursement Scenario
7.5.4.4 France Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.5 Italy
7.5.5.1 Key Country Dynamics
7.5.5.2 Regulatory Framework
7.5.5.3 Reimbursement Scenario
7.5.5.4 Italy Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.6 Spain
7.5.6.1 Key Country Dynamics
7.5.6.2 Regulatory Framework
7.5.6.3 Reimbursement Scenario
7.5.6.4 Spain Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.7 Denmark
7.5.7.1 Key Country Dynamics
7.5.7.2 Regulatory Framework
7.5.7.3 Reimbursement Scenario
7.5.7.4 Denmark Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.8 Norway
7.5.8.1 Key Country Dynamics
7.5.8.2 Regulatory Framework
7.5.8.3 Reimbursement Scenario
7.5.8.4 Norway Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.9 Sweden
7.5.7.1 Key Country Dynamics
7.5.7.2 Regulatory Framework
7.5.7.3 Reimbursement Scenario
7.5.7.4 Sweden Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6 Asia Pacific
7.6.1 Asia Pacific Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
7.6.2 Japan
7.6.2.1 Key Country Dynamics
7.6.2.2 Regulatory Framework
7.6.2.3 Reimbursement Scenario
7.6.2.4 Japan Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.3 China
7.6.3.1 Key Country Dynamics
7.6.3.2 Regulatory Framework
7.6.3.3 Reimbursement Scenario
7.6.3.4 China Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.4 India
7.6.4.1 Key Country Dynamics
7.6.4.2 Regulatory Framework
7.6.4.3 Reimbursement Scenario
7.6.4.4 India Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.5 South Korea
7.6.5.1 Key Country Dynamics
7.6.5.2 Regulatory Framework
7.6.5.3 Reimbursement Scenario
7.6.5.4 South Korea Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.6 Australia
7.6.6.1 Key Country Dynamics
7.6.6.2 Regulatory Framework
7.6.6.3 Reimbursement Scenario
7.6.6.4 Australia Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.7 Thailand
7.6.7.1 Key Country Dynamics
7.6.7.2 Regulatory Framework
7.6.7.3 Reimbursement Scenario
7.6.7.4 Thailand Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7 Latin America
7.7.1 Latin America Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
7.7.2 Brazil
7.7.2.1 Key Country Dynamics
7.7.2.2 Regulatory Framework
7.7.2.3 Reimbursement Scenario
7.7.2.4 Brazil Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.3 Argentina
7.7.3.1 Key Country Dynamics
7.7.3.2 Regulatory Framework
7.7.3.3 Reimbursement Scenario
7.7.3.4 Argentina Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8 Middle East & Africa
7.8.1 Middle East & Africa Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
7.8.2 South Africa
7.8.2.1 Key Country Dynamics
7.8.2.2 Regulatory Framework
7.8.2.3 Reimbursement Scenario
7.8.2.4 South Africa Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.3 Saudi Arabia
7.8.3.1 Key Country Dynamics
7.8.3.2 Regulatory Framework
7.8.3.3 Reimbursement Scenario
7.8.3.4 Saudi Arabia Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.4 UAE
7.8.4.1 Key Country Dynamics
7.8.4.2 Regulatory Framework
7.8.4.3 Reimbursement Scenario
7.8.4.4 UAE Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.5 Kuwait
7.8.5.1 Key Country Dynamics
7.8.5.2 Regulatory Framework
7.8.5.3 Reimbursement Scenario
7.8.5.4 Kuwait Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1 Bayer
8.5.1.1 Overview
8.5.1.2 Financial Performance
8.5.1.3 Product Benchmarking
8.5.1.4 Strategic Initiatives
8.5.2 Lantheus Holdings
8.5.2.1 Overview
8.5.2.2 Financial Performance
8.5.2.3 Product Benchmarking
8.5.2.4 Strategic Initiatives
8.5.3 POINT Biopharma
8.5.3.1 Overview
8.5.3.2 Financial Performance
8.5.3.3 Product Benchmarking
8.5.3.4 Strategic Initiatives
8.5.4 Telix Pharmaceuticals
8.5.4.1 Overview
8.5.4.2 Financial Performance
8.5.4.3 Product Benchmarking
8.5.4.4 Strategic Initiatives
8.5.5 Actinium Pharmaceuticals
8.5.5.1 Overview
8.5.5.2 Financial Performance
8.5.5.3 Product Benchmarking
8.5.5.4 Strategic Initiatives
8.5.6 RadioMedix
8.5.6.1 Overview
8.5.6.2 Financial Performance
8.5.6.3 Product Benchmarking
8.5.6.4 Strategic Initiatives
8.5.7 IsoRay
8.5.7.1 Overview
8.5.7.2 Financial Performance
8.5.7.3 Product Benchmarking
8.5.7.4 Strategic Initiatives
8.5.8 SHINE Technologies
8.5.8.1 Overview
8.5.8.2 Financial Performance
8.5.8.3 Product Benchmarking
8.5.8.4 Strategic Initiatives
8.5.9 NorthStar Medical Radioisotopes
8.5.9.1 Overview
8.5.9.2 Financial Performance
8.5.9.3 Product Benchmarking
8.5.9.4 Strategic Initiatives
8.5.10 Fusion Pharmaceuticals
8.5.10.1 Overview
8.5.10.2 Financial Performance
8.5.10.3 Product Benchmarking
8.5.10.4 Strategic Initiatives
8.5.11 Novartis
8.5.11.1 Overview
8.5.11.2 Financial Performance
8.5.11.3 Product Benchmarking
8.5.11.4 Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Radiotheranostics Market Market, by Region, 2021-2033 (USD Million)
Table 4 Global Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 5 Global Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 6 Global Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 7 North America Radiotheranostics Market Market, by Country, 2021-2033 (USD Million)
Table 8 North America Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 9 North America Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 10 North America Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 11 U.S. Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 12 U.S. Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 13 U.S. Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 14 Canada Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 15 Canada Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 16 Canada Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 17 Mexico Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 18 Mexico Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 19 Mexico Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 20 Europe Radiotheranostics Market Market, by Country, 2021-2033 (USD Million)
Table 21 Europe Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 22 Europe Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 23 Europe Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 24 UK Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 25 UK Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 26 UK Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 27 Germany Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 28 Germany Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 29 Germany Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 30 France Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 31 France Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 32 France Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 33 Italy Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 34 Italy Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 35 Italy Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 36 Spain Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 37 Spain Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 38 Spain Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 39 Denmark Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 40 Denmark Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 41 Denmark Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 42 Norway Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 43 Norway Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 44 Norway Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 45 Sweden Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 46 Sweden Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 47 Sweden Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 48 Asia Pacific Radiotheranostics Market Market, by Country, 2021-2033 (USD Million)
Table 49 Asia Pacific Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 50 Asia Pacific Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 51 Asia Pacific Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 52 Japan Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 53 Japan Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 54 Japan Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 55 China Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 56 China Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 57 China Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 58 India Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 59 India Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 60 India Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 61 South Korea Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 62 South Korea Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 63 South Korea Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 64 Australia Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 65 Australia Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 66 Australia Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 67 Thailand Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 68 Thailand Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 69 Thailand Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 70 Latin America Radiotheranostics Market Market, by Country, 2021-2033 (USD Million)
Table 71 Latin America Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 72 Latin America Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 73 Latin America Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 74 Brazil Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 75 Brazil Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 76 Brazil Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 77 Argentina Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 78 Argentina Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 79 Argentina Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 80 Middle East & Africa Radiotheranostics Market Market, by Country, 2021-2033 (USD Million)
Table 81 Middle East & Africa Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 82 Middle East & Africa Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 83 Middle East & Africa Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 84 South Africa Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 85 South Africa Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 86 South Africa Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 87 Saudi Arabia Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 88 Saudi Arabia Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 89 Saudi Arabia Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 90 UAE Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 91 UAE Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 92 UAE Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
Table 93 Kuwait Radiotheranostics Market Market, by Radioisotope, 2021-2033 (USD Million)
Table 94 Kuwait Radiotheranostics Market Market, by Approach, 2021-2033 (USD Million)
Table 95 Kuwait Radiotheranostics Market Market, by Application, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in APAC
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Radiotheranostics Market: market outlook
Figure 14 Radiotheranostics Market: competitive insights
Figure 15 Parent market outlook
Figure 16 Related/ancillary market outlook
Figure 17 Penetration and growth prospect mapping
Figure 18 Industry value chain analysis
Figure 19 Radiotheranostics Market driver impact
Figure 20 Radiotheranostics Market restraint impact
Figure 21 Radiotheranostics Market strategic initiatives analysis
Figure 22 Radiotheranostics Market: Radioisotope movement analysis
Figure 23 Radiotheranostics Market: Radioisotope outlook and key takeaways
Figure 24 Iodine-131 market estimates and forecast, 2021-2033
Figure 25 Iodine-123 market estimates and forecast, 2021-2033
Figure 26 Gallium-68 market estimates and forecast, 2021-2033
Figure 27 Lutetium-177 market estimates and forecast, 2021-2033
Figure 28 18F with Y-90 market estimates and forecast, 2021-2033
Figure 29 Others market estimates and forecasts, 2021-2033
Figure 30 Radiotheranostics Market: Approach movement analysis
Figure 31 Radiotheranostics Market: Approach outlook and key takeaways
Figure 32 Targeted Therapeutic market estimates and forecast, 2021-2033
Figure 33 Targeted Diagnostic market estimates and forecast, 2021-2033
Figure 34 Radiotheranostics Market: Application movement analysis
Figure 35 Radiotheranostics Market: Application outlook and key takeaways
Figure 36 Oncology market estimates and forecast, 2021-2033
Figure 37 Thyroid Cancer market estimates and forecast, 2021-2033
Figure 38 Neuroendocrine Tumor market estimates and forecast, 2021-2033
Figure 39 Hepatocellular Carcinoma market estimates and forecast, 2021-2033
Figure 40 Prostate Cancer market estimates and forecast, 2021-2033
Figure 41 Others market estimates and forecasts, 2021-2033
Figure 42 Non-Oncology market estimates and forecast, 2021-2033
Figure 43 Neurological Disorders market estimates and forecast, 2021-2033
Figure 44 Arthritis market estimates and forecast, 2021-2033
Figure 45 Others market estimates and forecasts, 2021-2033
Figure 46 Radiotheranostics Market: Regional movement analysis
Figure 47 Radiotheranostics Market: Regional outlook and key takeaways
Figure 48 Radiotheranostics Market share and leading players
Figure 49 North America Radiotheranostics Market share and leading players
Figure 50 Europe Radiotheranostics Market share and leading players
Figure 51 Asia Pacific Radiotheranostics Market share and leading players
Figure 52 Latin America Radiotheranostics Market share and leading players
Figure 53 Middle East & Africa Radiotheranostics Market share and leading players
Figure 54 North America Radiotheranostics Market SWOT Analysis
Figure 55 Europe Radiotheranostics Market SWOT Analysis
Figure 56 Asia Pacific Radiotheranostics Market SWOT Analysis
Figure 57 Latin America Radiotheranostics Market SWOT Analysis
Figure 58 Middle East & Africa Radiotheranostics Market SWOT Analysis
Figure 59 North America Radiotheranostics Market Analysis, by country
Figure 60 North America
Figure 61 North America Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 62 U.S.
Figure 63 U.S. Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 64 Canada
Figure 65 Canada Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 66 Mexico
Figure 67 Mexico Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 68 Europe
Figure 69 Europe Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 70 UK
Figure 71 UK Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 72 Germany
Figure 73 Germany Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 74 France
Figure 75 France Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 76 Italy
Figure 77 Italy Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 78 Spain
Figure 79 Spain Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 80 Denmark
Figure 81 Denmark Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 82 Sweden
Figure 83 Sweden Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 84 Norway
Figure 85 Norway Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 86 Asia Pacific
Figure 87 Asia Pacific Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 88 China
Figure 89 China Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 90 Japan
Figure 91 Japan Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 92 India
Figure 93 India Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 94 Thailand
Figure 95 Thailand Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 96 South Korea
Figure 97 South Korea Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 98 Australia
Figure 99 Australia Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 100 Latin America
Figure 101 Latin America Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 102 Brazil
Figure 103 Brazil Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 104 Argentina
Figure 105 Argentina Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 106 Middle East & Africa
Figure 107 Middle East & Africa Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 108 South Africa
Figure 109 South Africa Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 110 Saudi Arabia
Figure 111 Saudi Arabia Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 112 UAE
Figure 113 UAE Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 114 Kuwait
Figure 115 Kuwait Radiotheranostics Market Estimates and Forecasts 2021-2033
Figure 116 Market share of key market players - Radiotheranostics Market

Companies Mentioned

The leading players profiled in this Radiotheranostics market report include:
  • Novartis
  • Bayer
  • Lantheus Holdings
  • POINT Biopharma
  • Telix Pharmaceuticals
  • Actinium Pharmaceuticals
  • RadioMedix
  • IsoRay
  • SHINE Technologies
  • NorthStar Medical Radioisotopes
  • Fusion Pharmaceuticals

Table Information

Report AttributeDetails
No. of Pages150
PublishedJanuary 2026
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 11.79 Billion
Forecasted Market Value ( USD ) by 2033 $ 25.56 Billion
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Radiotheranostics - Global Strategic Business Report - Product Image

Radiotheranostics - Global Strategic Business Report

  • Report
  • 168 Pages
  • Global
From
Radiotheranostics Market Report 2026 - Product Image

Radiotheranostics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Radiotheranostics Market Report and Forecast 2025-2034 - Product Image

Radiotheranostics Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Radiotheranostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Radiotheranostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Iodine-131 Isotope Market - Global Forecast 2026-2032 - Product Image

Iodine-131 Isotope Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.